For FY25, monday.com has raised its full-year guidance outlook to $1.22-$1.226 billion in revenue, representing a 25-26% y/y ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

Learn why market extremes create opportunities and how to invest smartly despite risks. See here for two deep-value stocks ...

AI workload demands continue to expand, with generative AI a driver of further investment in infrastructure. As organizations ...

The worst-case scenario of a severe recession is now off the table. Read more on three investments to take advantage of a ...

The benefits of financial independence extend far beyond the financial realm. Read about three undervalued dividend growth ...

Amazon's balance sheet is one of the strongest on the planet, boasting an AA credit rating from S&P on a stable outlook. Read ...

Macy’s faces core sales pressure and leadership uncertainty despite luxury strength, dimming its near-term outlook and ...